Screener / SEC EDGAR /CIK 0000790526 /10-K filed Mar 2, 2026, compared with Mar 3, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Medical Labs

RadNet, Inc. RDNT

Compare with peers Embed
What it said it expected, against what it reported

1 target with a reported result

Releases of the last 3 years
Above the range 1 above the last range given
Within the range 0 of 1 range targets
Below the range 0 below the last range given

The numbers RDNT said it expected, in its earnings releases, next to what it then reported for the same period.

Target by target

Each target, with the sentence it came from · release and 10-Q or 10-K

The last range givenReported, abovewithin or keptbelow or missed
TargetWhat the company saidReportedResult
EBITDA (company-defined)
Fiscal 2026
Given $335.00M to $348.00M release Mar 2, 2026
– No standard number
The company's words
Guidance Range … Adjusted EBITDA(1) $335 - $348 million release Mar 2, 2026
Free cash flow (company-defined)
Fiscal 2026
Given $105.00M to $115.00M release Mar 2, 2026
– No standard number
The company's words
Guidance Range … Free Cash Flow(2) $105 - $115 million release Mar 2, 2026
Capital expenditures
Fiscal 2026
Given $165.00M to $175.00M release Mar 2, 2026
– Not reported yet
The company's words
Guidance Range … Capital Expenditures(a) $165 - $175 million release Mar 2, 2026
Revenue
Fiscal 2026
Given $135.00M to $145.00M release Mar 2, 2026
– Not reported yet
The company's words
Guidance Range … Total Net Revenue(a) $135 - $145 million release Mar 2, 2026
EBITDA (company-defined)
Fiscal 2025 (ended Dec 31, 2025)
Given $265.00M to $273.00M release Mar 5, 2025
– No standard number
The company's words
Guidance Range … Adjusted EBITDA(1) $265 - $273 million release Mar 5, 2025
Free cash flow (company-defined)
Fiscal 2025 (ended Dec 31, 2025)
Given $70.00M to $80.00M release Mar 5, 2025
– No standard number
The company's words
Guidance Range … Free Cash Flow(2) $70 - $80 million release Mar 5, 2025
Capital expenditures
Fiscal 2025 (ended Dec 31, 2025)
Given $140.00M to $150.00M release Mar 5, 2025
– Not found in XBRL
The company's words
Guidance Range … Capital Expenditures(a) $140 - $150 million release Mar 5, 2025
Revenue
Fiscal 2025 (ended Dec 31, 2025)
Given $1.82B to $1.88B release Mar 5, 2025
$2.04B
10-K filed 2026-03-02
Above the range
The company's words
Guidance Range … Total Net Revenue $1,825 - $1,875 million release Mar 5, 2025
1 target far from the company's reported total, so not compared (usually a target for one product, segment or definition)
  • Revenue, Fiscal 2024 (ended Dec 31, 2024): said $60.00M to $70.00M, reported $1.83B. The company's words

Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (12 releases since 2024-03-05), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.

Sources

The outlook sentences of each earnings release (8-K item 2.02, exhibit 99), read without AI; results from SEC's XBRL company facts, as first reported.

Also

Earnings releases: each release in full.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/RDNT/export.csv") into a cell.

Next:Archive
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.